Table 2 Clinical and biochemical characteristics of patients with FCHL according to vitamin D status
From: Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment
Deficient (n = 46) | Sufficient (n = 13) | P | |
|---|---|---|---|
Age (years) | 51.7 ± 10.3 | 44.9 ± 14.5 | 0.061 |
BMI (Kg/m2) | 28.2 ± 4.0 | 26.8 ± 4.0 | 0.289 |
Waist (cm) | 96.2 ± 10.1 | 93.3 ± 12.8 | 0.412 |
HbA1c (%) | 5.6 ± 0.5 | 5.6 ± 0.4 | 0.838 |
HOMA | 2.7 ± 2.4 | 1.8 ± 0.9 | 0.838 |
Total cholesterol (mmol/L) | 6.6 ± 1.6 | 7.1 ± 1.3 | 0.335 |
Triglycerides (mmol/L) | 2.5 (1.1-15.8) | 2.0 (1.2-3.1) | 0.041 |
LDL-c (mmol/L) | 3.9 ± 1.2 | 4.8 ± 1.3 | 0.025 |
HDL-c (mmol/L) | 1.1 ± 0.4 | 1.3 ± 0.3 | 0.051 |
VLDL-c (mmol/L) | 1.1 (0.5-7.6) | 0.9 (0.6-1.3) | 0.079 |
NEFA (mmol/L) | 0.7 (0.3-4.3) | 0.5 (0.2-1.1) | 0.015 |
ApoB (g/L) | 1.3 ± 0.3 | 1.4 ± 0.3 | 0.116 |
LDL size (nm) | 25.4 ± 0.7 | 25.7 ± 0.4 | 0.184 |
CRP (mg/L) | 1.6 (0.3-21.1) | 1.5 (0.2-21.5) | 0.901 |
25(OH)D (nmol/L) | 48.2 ± 14.3 | 96.9 ± 11.7 | 0.000 |